Physician profile
Melanie J Dresden
NPI 1720501315
$4,046.02
in general payments reported to CMS, 2019-2025
9 companies · $69.34 in 2025
The $69.34 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $109 · 2022: $2,944 · 2023: $268 · 2024: $656 · 2025: $69.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $993.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $992.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,560.00 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $691.11 | 2021-2025 | Dupixent |
| Genzyme Corporation | $588.45 | 2023-2025 | |
| Alk-Abello, INC | $99.86 | 2021-2022 | |
| Aerin Medical INC. | $27.61 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.77 | 2023 | |
| Hikma Pharmaceuticals USA | $18.81 | 2024 | Ryaltris |
| Stryker Corporation | $18.23 | 2021 | |
| Merck Sharp & Dohme LLC | $15.18 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Dresden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.